Ethics. Human health research ethics.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to S Lerman.
Explore the source record for details and available documents.
BACKGROUND: Integrins such as VLA-4 (Very late antigen 4, integrin alpha4beta1) play key roles in cell-cell interactions that are critical for development. Homozygous null knockouts of the VLA-4 alpha4-subunit or VCAM-1 (VLA-4 cell surface ligand) in mice result in failure of the allantois and chorion to fuse leading to interrupted placentation and cardiac development and embryo lethality. Embryo-fetal studies of three VLA-4 antagonists, IVL745, IVL984, and HMR1031 [Crofts et al., Birth Defects Res B 71:55-68 (this issue), 2004] with exposure on gestation days (GD) 6-17 (rat), 6-18 (rabbit) or 6-15 (mouse) showed that only IVL984 treatment resulted in embryo lethality and cardiac defects. Objectives of the current study were to determine the critical period for inducing IVL984-related embryo-fetal effects, and to test the hypothesis that these effects were due to higher embryo drug concentrations. METHODS: IVL984 was administered at 40 mg/kg/day to pregnant rats on GD 4 and 5, GD 6 and 7, GD 8 and 9, GD 10 and 11, or GD 12 and 13. Animals were euthanized on GD 21 and uteri and fetuses were examined. A treatment period of GD 10-12 was selected for subsequent toxicokinetic (TK) studies in which IVL984, HMR1031, or IVL745 was administered to pregnant rats and rabbits. On GD 12, maternal plasma, extra-embryonic tissue (placenta and amniotic fluid), and embryonic tissue were collected and analyzed for drug concentrations. RESULTS: In the IVL984 critical period study in pregnant rats, treatment on GD 10 and 11 resulted in increased post-implantation loss, skeletal variations, and spiral septal defects similar to those observed in standard embryo-fetal development studies with treatment throughout organogenesis. There were no embryo-fetal effects after treatment on GD 4 and 5, GD 6 and 7, or GD 8 and 9. There was a single aorta malformation after treatment on GD 12 and 13. In the TK studies, IVL745, HMR1031, and IVL984 were all detectable in embryonic tissue and there was no evidence for accumulation. Rat and rabbit embryo exposures (AUC or dose-adjusted AUC) on GD 12 could not explain the observed teratology (IVL984<HMR1031<IVL745). Further analyses incorporating pharmacological activity, clearance, and protein binding data provided a positive correlation between embryonic exposure and teratogenic potency. CONCLUSIONS: The critical period for IVL984 in the rat, GD 10 to 11, corresponds to the expression of alpha-4 integrin on the chorion and VCAM-1 on the allantois and myocardium as well as chorioallantoic fusion and formation of the spiral septum. Embryo drug levels adjusted for pharmacological activity, clearance, and protein binding provide a possible explanation for the differing teratogenic potency of IVL984, HMR1031, and IVL745.
BACKGROUND: VLA-4 (Very late antigen 4, integrin alpha4beta1) plays an important role in cell-cell interactions that are critical for development. Homozygous null knockouts of the alpha4 subunit of VLA-4 or VCAM-1 (cell surface ligand to VLA-4) in mice result in abnormal placental and cardiac development and embryo lethality. Objectives of the current study were to assess and compare the teratogenic potential of three VLA-4 antagonists. METHODS: IVL745, HMR1031, and IVL984 were each evaluated by the subcutaneous route in standard embryo-fetal developmental toxicity studies in rats and rabbits. IVL984 was also evaluated in mice. Fetuses were examined externally, viscerally, and skeletally. RESULTS: IVL745 did not cause significant maternal or fetal effects at doses up to 100 or 250 mg/kg/day in rats or rabbits, respectively. HMR1031 treatment resulted in marked maternal toxicity and slight fetal toxicity at the highest tested doses of 200 and 75 mg/kg/day in rats and rabbits, respectively. HMR1031 embryo-fetal effects consisted of slightly lower body weight and crown-rump length in rats and minor sternebral defects in rabbits. IVL984 treatment resulted in minimal maternal effects at doses up to 40, 15, and 100 mg/kg/day in rats, rabbits, and mice, respectively (excluding abortions in rabbits). However, marked developmental effects were observed at the lowest tested IVL984 doses, 1, 0.2, and 3 mg/kg/day in rats, rabbits, and mice, respectively. IVL984 embryo-fetal effects consisted of increased total post-implantation loss due to early resorptions and high incidences of cardiac malformations and skeletal malformations and/or variations. Notably, spiral septal defects were observed in up to 76% of rat fetuses and up to 58% of rabbit fetuses. CONCLUSIONS: Dramatic differences in teratogenic potential were observed: IVL745 was not teratogenic, HMR1031 caused slight embryo-fetal effects at maternally-toxic doses, and IVL984 was a potent teratogen at doses where direct maternal toxicity was limited to abortions in rabbits. Prominent effects of IVL984 included embryo lethality and cardiac malformations including spiral septal defects in three species.
Lymphomas (formerly reticulum cell sarcomas (RCS)) which develop spontaneously in SJL mice are a murine counterpart of human low grade B-cell non-Hodgkin's lymphoma. Tumor cells stimulate proliferation of syngeneic CD4+ T-lymphocytes which secrete cytokines required for tumor growth. Cyclophosphamide treatment of tumor-bearing mice (RCS/Cy) decreases in vitro tumor-stimulated CD4+ T-cell proliferation and, in turn, tumor growth, in part, through the suppressive action of CD8+ T-lymphocytes. In RCS/Cy compared to untreated tumor-bearing (RCS5) mice we report marked in vivo decreases in: (1) the activation (CD44HI/CD45RBLO phenotype) and proliferation (S + G2M phases of the cell cycle) of CD4+ T-lymphocytes; (2) the ratio of activated and/or proliferating CD4+ to CD8+ T-lymphocytes, and; (3) the proliferation of tumor cells. Also, depletion of CD8+ T-lymphocytes from RCS/Cy mice abrogated much of the efficacy of the RCS/Cy treatment and led to changes in lymphoid populations more reminiscent of those in RCS5 than RCS/Cy mice. The data support our hypothesis that the RCS/Cy treatment achieves its efficacy by preventing the predominance of CD4+ over CD8+ T-lymphocytes which is essential to maximum tumor growth in RCS5 mice. The results imply that analogous B-cell lymphomas in humans also may be treatable by shifting the T-cell balance toward inhibitory CD8+ rather than the tumor-stimulatory CD4+ T-lymphocytes.
Fluorescence polarization and near UV circular dichroism (CD) studies were performed on four purified human gamma crystallin fractions derived from normal (eye bank lenses) ranging in age from the first decade through the seventh decade. All the four young (first decade) gamma crystallins had higher polarization values compared with the old (sixth and seventh decade) fractions: in addition, the CD spectra of the gamma I and II crystallins show substantial aging differences; marked decrease in intensity of the negative tryptophan band near 290 nm. While this effect is much less pronounced in the gamma III and IV fractions, aging changes in other areas of some of these fractions also occur. These data demonstrate significant alterations occurring in the human gamma crystallins associated with the normal aging process. Specific conformational alterations are proposed to account for these changes.
During the past two decades progress in biophysical technology has made it possible to monitor aging and pre-cataractous as well as cataractous changes in the ocular lens in vivo as well as in vitro. Because they are non-invasive these techniques can be performed in vivo and utilized as screening methods to detect and predict eventual lens opacification, and they should also provide increasingly important information to help clarify the cataractogenic process. Three such biophysical approaches can now be employed in vivo; these include lens fluorescence, light scattering measurements and magnetic resonance imaging (MRI) T2 analyses (1-27). We have utilized two of these methods (fluorescence spectroscopy and MRI measurements of lens water [T2] phases) to delineate normal age-related and pre-cataractous changes in a series of human subjects and in patients with early lens opacities. The parameters employed for these studies were based on data accumulated from in vitro experiments on human lenses and in vivo and in vitro data from animal experiments (2, 6-8, 18, 19, 22, 25-27).
This manuscript represents an attempt to evaluate the methods used to assess the biostability of IOLs, in particular their leaching characteristics, the effects of laser pitting, their tensile strength and the effects of UV irradiation on long term implantation of IOLs. The literature relating to these topics during the last two decades has been reviewed and experimental study protocols are presented.
The recent interest in treating acne with one of the retinoid drugs has been accompanied by a wide variety of ocular side effects involving the eyelids, cornea, lens, optic nerve and retina. In one group of patients being evaluated for possible efficacy of a retinoic acid analogue in treating psoriasis, several patients complained of difficulty driving at night due to decreased dark adaptation which we were able to document. Fortunately, most of the above side effects tend to disappear within months after the drug is discontinued. However, we have recently seen two cases of dry eye syndrome associated with Accutane therapy that have persisted for more than two years. In addition, scattered reports have appeared regarding cataracts in young patients (teens to early 40's) which developed during, and/or after Accutane treatment. We have examined lens matter derived from two such patients who had extracapsular cataract extractions. Their lens proteins showed an elevation in UV absorptivity (between 330-390 nm) compared with matched control material (derived from Eye Bank specimens) and HPLC analyses demonstrated an abnormal peak in their profiles which was similar to one present in control samples incubated with retinoic acid and was not present in lens protein samples derived from cataracts not associated with Accutance therapy. These observations demonstrate that some of the Accutane induced ocular side affects are not reversible when the drug is stopped, and patients on such therapy should be carefully monitored.
Explore the source record for details and available documents.
In this article,the uses of photobiologic techniques such as ultraviolet B radiation and PUVA are discussed, as is a general review of their potential acute and chronic side effects. The authors then focus, in more extensive detail, on the potential acute and chronic ocular toxicity associated with these modalities.
Progress in biophysical technology now permits us to monitor aging and precataractous changes in the human ocular lens in vivo as well as in vitro. We are employing two noninvasive techniques to measure changes in lens fluorescence and in one lens water compartment (T2) utilizing Scheimpflug lens fluorescence densitography and magnetic resonance imaging. These studies demonstrate age-related changes in the normal lens as reflected by enhanced fluorescence and longer T2 values. Precataractous changes can also be detected with this approach.
Our laboratory has demonstrated the cataractogenic potential of UV radiation and several photosensitizing drugs in laboratory animals and in humans. We have utilized lens fluorescence measurements (which we have demonstrated to be a reliable marker for pre-cataractous and early cataractous changes), NMR pulse relaxation techniques, and our recently developed magnetic resonance imaging method to measure lens T2 values in the normal and UV exposed Degus lens (in vivo and in vitro) to detect pre-cataractous changes in the lens. These approaches will permit us to employ two parameters (increased non-tryptophan fluorescence and a decrease in T2 values) to monitor for such changes months before the lens opacities become manifest by conventional slit lamp examinations.
The tryptophan residues within the alpha, beta and gamma crystallins (derived from normal human lenses ranging in age from the 1st through the 7th decade) were examined by fluorescence polarization (FP) and near UV circular dichroism (CD) techniques. These experiments demonstrate an age-related difference mainly in the gamma crystallin fraction in which the polarization and CD data demonstrate changes in the old gamma (7th decade) compared with the young gamma fraction (1st-3rd decade). Young gamma has the highest stability and is one of the most compact of the lens crystallins, as reflected by the FP and CD studies, and these parameters decrease significantly in the old gamma fraction. The loss of one of the gamma fractions as the lens ages may also be correlated with these age-related changes. There were no significant aging changes in the beta crystallins, while the alpha crystallins demonstrated a moderate FP change with age.
Explore the source record for details and available documents.
Ten patients with untreated Graves' disease underwent tests to determine lactose absorption, liquid gastric emptying, and oral cecal transit time. To determine the influence of thyroid hormone status on lactose absorption, eight of these same patients had repeat studies when rendered euthyroid. Two of these eight patients also underwent studies while transiently hypothyroid. Motility studies were also evaluated in a group of 11 control subjects. Lactose malabsorption occurred in nine patients with Graves' disease. In seven patients who repeated these studies, lactose malabsorption normalized in three, symptoms induced by lactose improved in two and were unchanged in two. However, these latter two patients appeared to have improved symptoms in the transient hypothyroid state. Liquid gastric emptying was significantly faster in untreated patients than controls and treated self-same patients. Transit time was significantly faster in untreated patients than when they were rendered euthyroid. There may be a relationship between altered lactose absorption states and changes in intestinal motility in patients with Graves' disease.
Our laboratory has demonstrated the potential of non-invasive biophysical methods in studying cataractogenesis. Initially these studies involved in vitro spectroscopic assays (UV, fluorescence and phosphorescence) on excised lenses or lens matter. In addition, we performed NMR pulse relaxation studies on extracted lenses which demonstrated an age-related increase in the T1 and T2 values of the normal lens. The in vitro fluorescence and NMR data suggested potential parameters for monitoring human and animal lenses in vivo. We then developed in vivo lens fluorescence densitography utilizing the Scheimpflug camera and have recently employed our Magnetic Resonance Imaging (MRI) method (using specially constructed small coils) to measure the moderately bound lens water compartment (T2) in vivo. Both of these in vivo methods correlate with our in vitro data and they demonstrate age-related changes in the normal lens; - i.e. - a progressive increase in fluorescence intensity and longer T2 values. Indices have been developed which permit us to detect abnormal lens fluorescence and changes in the moderately bound lens water (T2) compared with normal values for each specific age group by decade. These 2 non-invasive biophysical techniques can detect pre-cataractous changes in the living clear lens, months to years before any type of opacity becomes manifest with the conventional slit lamp method. The MRI technique can be performed in less than 20 minutes and the lens fluorescence method requires 4-6 minutes; thus they provide a rapid and objective in vivo measure of the status of the living lens as well as a method for evaluating anti-cataract drug efficacy.
A case of parathyroid cyst is reported in which the diagnosis was suggested when watery, clear fluid was aspirated from a mass found in the anterior region of the neck of a 34-year-old woman on routine medical examination. The diagnosis was confirmed by measurement of the parathormone content in the cyst fluid and by histologic examination of the cyst wall. Although rare, parathyroid cyst should be considered in the differential diagnosis of cysts in the anterior compartment of the neck. Surgery has been the usual treatment of such cysts, but several reports have been published in which repeated aspiration resulted in the disappearance of the cyst. If conservative treatment of a parathyroid cyst is unsuccessful, the cyst should be removed surgically.
When monitoring for drug induced lenticular side effects and/or anti-cataract drug efficacy, it would be advantageous to detect such effects prior to the onset of a cataract. Our MRI technique can detect precataractous changes in the lens water compartments (T2 values) months to years before opacities become manifest. The in vivo human and animal studies correlate well with in vitro NMR pulse relaxation data on such lenses. The MRI technique requires 2-4 minutes per eye and provides excellent pictures of the globe as well as T2 values. These data correlate well with our in vivo lens fluorescence technique thereby providing two parameters capable of evaluating potential drug induced changes in the lens well before the cataract becomes manifest.